Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Of hu14.18-IL2 In Children With Recurrent Or Refractory Neuroblastoma

NCT00082758 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00082758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00082758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Of hu14.18-IL2 In Children With Recurrent Or Refractory Neuroblastoma
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2005
Completion date
May 31, 2012
Enrollment
39 (actual)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma